PG Form 4: 197 Restricted Stock Units Granted to Kempczinski
Rhea-AI Filing Summary
Christopher J. Kempczinski, a director of Procter & Gamble Co (PG), was awarded 197 Restricted Stock Units (RSUs) on 09/09/2025 under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The RSUs were granted at a price of $0 and the reported total beneficial ownership after the award is 9,166.4401 common shares, which includes dividend equivalents credited as additional RSUs. The filing reports the grant as a non‑derivative equity award and identifies the award as restricted stock units and dividend equivalents; no options, sales, or cash transactions are disclosed.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine executive equity grant; maintains alignment with shareholders without indicating material ownership change.
The 197 RSU award to Christopher Kempczinski is documented as a standard restricted stock unit grant under P&G's 2019 plan. Such grants are commonly used to align management incentives with long‑term shareholder value. The transaction increases reported beneficial ownership to 9,166.4401 shares including dividend equivalents, but the absolute size appears routine for executive compensation and does not, on its face, represent a material change in control or ownership percentage.
TL;DR: Compensation action is standard; structure (RSUs plus dividend equivalents) preserves retention and long‑term orientation.
The award is categorized as restricted stock units with dividend equivalents, which suggests standard retention and incentive design rather than a performance‑contingent payout. The grant price is reported as $0, consistent with time‑based RSUs that convert to shares upon vesting. There is no indication of accelerated vesting, option exercise, or cash payments, reinforcing that this is a routine equity compensation event.